Latest Shareholder Agreements News

Bannerman Energy has completed CNOL’s US$320.4 million strategic investment in the Etango uranium project, giving the joint venture approximately US$303 million in cash and a debt-free construction pathway. The project now moves towards a Final Investment Decision and full-scale construction targeted for Q4 2026.

Deep Yellow Limited has locked in two pivotal agreements for its Tumas uranium project in Namibia, securing long-term water supply and formalising local ownership with Oponona Investments. These milestones pave the way for construction progress and a Final Investment Decision expected later this year.

Centrepoint Alliance has acquired a 51% controlling interest in SEQ Advice Group, targeting an initial $0.6 million EBITDA boost and a path to $1.9 million by FY31 through increased ownership.

Strike Resources is progressing the sale of a 28.52% indirect stake in its high-grade Apurímac Iron Ore Project for A$5.5 million, while advancing exploration programs and preparing for potential small-scale mining under Peru’s artisanal regime. The company also holds a 27.7% interest in LE Minerals, which is spinning out its Graphite Projects via an IPO.

The Takeovers Panel has refused to proceed with a disclosure dispute application related to Atlas Arteria’s off-market takeover bid and its handling of a right of first offer notice for the Chicago Skyway asset.

Diamond Infraco, backed by IFM Global Infrastructure Fund, has lodged a Takeovers Panel application alleging material disclosure deficiencies in Atlas Arteria's takeover bid documents, centering on governance rights tied to the Chicago Skyway asset.

Strike Resources has agreed to sell a further 28.52% indirect stake in its Apurimac Iron Ore Project to JE United Ltd for A$5.5 million, while securing a US$5 million credit facility to accelerate project development and iron ore marketing.

Ramsay Health Care is set to simplify its corporate structure by distributing its majority stake in European healthcare provider Ramsay Santé directly to shareholders, enabling focused growth strategies for both entities.

Apiam Animal Health’s acquisition scheme by Adamantem Capital has been legally approved, leading to the suspension of its shares on the ASX. Key dates for dividend payments and scheme implementation are now set.

DXN Limited reported a 63% revenue decline in Q2 FY26 due to project delays but bolstered its future outlook with a $15 million backlog and a strategic joint venture in Indonesia.

Sarytogan Graphite Limited updates investors on its $5 million capital raising, highlighting regulatory approval delays but confirming near-term funding to advance its key graphite project.

AMA Group Limited secured strong shareholder approval across all resolutions at its 2025 Annual General Meeting, including capital consolidation and executive incentives.